How much funding has Recursion raised?

Recursion has raised $482.9M in total funding, most recently a Corporate Round.

Who are Recursion's investors?

Recursion's investors include DCVC (Data Collab), Lux Capital, Baillie Gifford, Nvidia, Leaps by Bayer, Obvious Ventures.

Where is Recursion headquartered?

Recursion is headquartered in Salt Lake City, Utah, United States.

What industry is Recursion in?

Recursion operates in Artificial Intelligence, Biotech, Drug Discovery.

How many employees does Recursion have?

Recursion has 501-1000 employees.

Recursion

formerly Recursion PharmaIPO

Decoding biology to radically improve lives

Public · Salt Lake City, United States · Founded 2013 · $482.9M raised

Artificial Intelligence

Biotech

Drug Discovery

Headquarters: Salt Lake City, Utah
Employees: 501–1000
Founded: 2013
Business Model: B2B
Website: recursion.com

Total Funding: $482.9M
Last Round: $50.0M Corporate RoundJul 2023
Rounds: 5
Type: Public

About

Recursion is a TechBio company that combines large-scale biological experimentation, proprietary datasets, and AI-driven machine learning to accelerate drug discovery and development. Operating its Recursion OS platform and BioHive-2 supercomputer built with NVIDIA, the company has generated over 50 petabytes of biological and chemical data to identify novel drug candidates and advance a pipeline of potential first-in-class therapies.

Summary

Recursion is an Artificial Intelligence company based in Salt Lake City, United States, founded in 2013. It has raised $482.9M in total across 5 rounds, most recently a $50.0M Corporate Round round in Jul 2023. Investors include DCVC (Data Collab), Lux Capital and Baillie Gifford.

LinkedIn X (Twitter)GitHub